Surmodics Inc expected to post a loss of 25 cents a share - Earnings Preview

SurModics

29/10/2021 15:05

* Surmodics Inc  SRDX.OQ   SRDX.O  is expected to show a rise in
quarterly revenue when it reports results on November 2
(estimated). 
* The Eden Prairie, Minnesota-based company is expected to
report  a 2.3% increase in revenue to $23.064 million from
$22.54 million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Surmodics Inc is for a
loss of 25 cents per share. For the same quarter last year, the
company reported a loss of 18 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Surmodics Inc
is $76​, about 28% above​ its last closing price of $54.71. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.15       -0.17      -0.17     Met     -2
 Mar. 31 2021  0.66        0.63       0.62      Missed  -2.1
 Dec. 31 2020  -0.08       -0.09      0.02      Beat    122.2​
 Sep. 30 2020  -0.07       -0.08      -0.18     Missed  -125
 Jun.          0.17​       0.19       0.21      Beat    8.6​
 30​ 2020​                                              
 Mar. 31 2020  -0.13       -0.11      0.04      Beat    137.5​
 Dec. 31 2019  -0.08       -0.08      0.05      Beat    162.5
 Sep. 30 2019  0.37        0.37       0.37      Met     0.9
 This summary was machine generated October 29 at 14:05 GMT.  All
figures in US dollars unless otherwise stated